NCT06809309 The Ventilation During In-hospital Cardiac Arrest Study
| NCT ID | NCT06809309 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Aarhus |
| Condition | Cardiac Arrest (CA) |
| Study Type | OBSERVATIONAL |
| Enrollment | 900 participants |
| Start Date | 2025-02-01 |
| Primary Completion | 2027-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 900 participants in total. It began in 2025-02-01 with a primary completion date of 2027-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this prospective observational study is to learn how ventilation quality parameters during cardiopulmonary resuscitation (CPR) are associated with short-term survival following in-hospital cardiac arrest of adult patients. The main questions it aims to answer are: What ventilation volume during CPR is associated with the highest chance of return of spontaneous circulation (ROSC)? What ventilation rate during CPR is associated with the highest chance of ROSC? Researchers will compare different levels of ventilation rates and volumes that are blindly measured during CPR to see how the observed rates and volumes are associated with survival outcomes and complications.
Eligibility Criteria
Inclusion Criteria: 1. In-hospital cardiac arrest 2. Age ≥ 18 years 3. \>1minute of recorded ventilation data Exclusion Criteria: 1. Documented do-not-attempt cardiopulmonary resuscitation order 2. Invasive mechanical circulatory support at the time of the cardiac arrest
Contact & Investigator
Johannes Wittig, MD
PRINCIPAL INVESTIGATOR
Department of Clinical Medicine, Aarhus University, Denmark; Department of Medicine, Randers Regional Hospital, Randers, Denmark; Research Center for Emergency Medicine, Aarhus University Hospital, Denmark
Frequently Asked Questions
Who can join the NCT06809309 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiac Arrest (CA). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06809309 currently recruiting?
Yes, NCT06809309 is actively recruiting participants. Contact the research team at johannes.wittig@clin.au.dk for enrollment information.
Where is the NCT06809309 trial being conducted?
This trial is being conducted at Aabenraa, Denmark, Aalborg, Denmark, Aarhus, Denmark, Esbjerg, Denmark and 7 additional locations.
Who is sponsoring the NCT06809309 clinical trial?
NCT06809309 is sponsored by University of Aarhus. The principal investigator is Johannes Wittig, MD at Department of Clinical Medicine, Aarhus University, Denmark; Department of Medicine, Randers Regional Hospital, Randers, Denmark; Research Center for Emergency Medicine, Aarhus University Hospital, Denmark. The trial plans to enroll 900 participants.